LGHTvsGNOMETF Comparison
Langar Global HealthTech ETF (LGHT) belongs to the Healthcare Technology segment. Global X Genomics & Biotechnology ETF (GNOM) is part of the BioTech & Genomics segment. LGHT's top 1 sector exposures are Healthcare. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.5% for GNOM. LGHT is up 2.6% year-to-date (YTD) with -$1M in YTD flows. GNOM performs better with 42.54% YTD performance, and +$16M in YTD flows. Run a side-by-side ETF comparison of LGHT and GNOM below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LGHT vs GNOM performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LGHT GNOM | +15.51%+18.42% | +25.50%+33.63% | +2.60%+42.54% | +0.98%+77.94% | n/a+44.48% | n/a-32.82% |
| Flows | LGHT GNOM | --$3M | -$522K+$16M | -$1M+$16M | -$941K+$10M | --$59M | --$37M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LGHT GNOM | +38.13%+39.29% | +25.51%+30.63% | n/a+30.39% | n/a+33.85% |
| Max drawdown | LGHT GNOM | -10.33%-8.57% | -25.58%-18.16% | n/a-43.10% | n/a-72.01% |
| Max drawdown duration | LGHT GNOM | 32d32d | 309d145d | n/a674d | n/a1825d |
LGHT | GNOM | |
Last sale 9/2/2026 at 2:24 PM | $65.36 | |
| Previous close 09/01/2026 | $64.76 | |
| Consolidated volume 09/01/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LGHT | GNOM | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LGHT | GNOM | |
|---|---|---|
| Last price | – | $65.36 |
| 1D performance | – | +0.92% |
| AuM | $2.36 M | $92.38 M |
| E/R | 0.85% | 0.5% |
LGHT | GNOM | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Langar Investment Management | Global X |
| Benchmark | - | Solactive Genomics Index |
| N° of holdings | 30 | - |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | January 10, 2024 | April 5, 2019 |
| ESG | Yes | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
